Sanofi Patient Group Bursary winners announced
27 June 2011 | By Sanofi
Sanofi announced the winners of the Sanofi Patient Group Bursary scheme - Breakthrough Breast Cancer and the MS Trust...
List view / Grid view
27 June 2011 | By Sanofi
Sanofi announced the winners of the Sanofi Patient Group Bursary scheme - Breakthrough Breast Cancer and the MS Trust...
24 June 2011 | By The Scott Partnership
MALS instruments represent the latest EP requirements for HES characterization....
24 June 2011 | By Boehringer Ingelheim
Boehringer Ingelheim and Eli Lilly received a positive opinion from the EMA's medicinal committee...
24 June 2011 | By Bristol-Myers Squibb
The Bristol-Myers Squibb Foundation awarded five grants totaling $1.5 million...
24 June 2011 | By Roche
Roche and Evotec AG announced a collaboration in novel protein-activity based biomarkers for Roche’s oncology drugs...
24 June 2011 | By Pfizer
Pfizer & Pain Therapeutics, Inc. received a Complete Response Letter from the U.S. FDA...
23 June 2011 | By Sanofi Pasteur
Sanofi Pasteur, announced that the WHO has granted prequalification to its Typhim Vi® polysaccharide typhoid vaccine...
23 June 2011 | By GlaxoSmithKline
GSK has agreed to pay $40.75 million, as part of an agreement...
23 June 2011 | By Roche
Roche announced the launch of a new R&D Institute in France...
22 June 2011 | By Novo Nordisk
Novo Nordisk is investing close to 1 billion Danish kroner (134 million euros) in a new factory in Kalundborg, Denmark...
22 June 2011 | By Velvet Communications Limited
Aesica Pharmaceuticals has announced the appointment of Nicolas Micheaud as Regional Sales Manager – Western Europe...
22 June 2011 | By Sanofi
To better leverage the real-world evidence generated during product development and throughout the product lifecycle...
22 June 2011 | By AstraZeneca
AstraZeneca has agreed to sell its Astra Tech business to DENTSPLY for approximately $1.8 billion in cash...
22 June 2011 | By The Scott Partnership
Novozymes Biopharma, will host a panel session at the BIO Business Forum...
21 June 2011 | By Eli Lilly and Company
Eli Lilly and Company, together with Amylin Pharmaceuticals, Inc. and Alkermes, Inc., announced that the European Commission has granted marketing authorization to BYDUREON™...